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ABSTRACT 
AIM: 
To Assess the incidence of thyroid dysfunction in patients receiving whole neck 
irradiation in head and neck malignancies.it is justified that   routinely  performed  
Thyroid function test (TFT) during routine follow up. 
 
Materials and methods: 
Fifty patients with locally advanced head and neck malignancies receiving whole 
neck irradiation for the period of one year were included in this study. Thyroid 
function tests (TFT) was done at baseline (Before start of treatment), after six 
months, and at the end of one year interval.   
 
 RESULTS: 
Out of fifty patients included in this study, 39(78%) were males and 11 
(22%)   were females. All patients received radiation to neck >40Gy. Among 50  
Patients received whole neck irradiation,20 patients had hypothyroidism with 
significant P value of 0.0001. 35 received chemotherapy concurrently and out of 
35 patients 18 had hypothyroidism with 51.42% and 15 patients received only 
radiotherapy out of 15 patients 2 had hypothyroidism with 13.33%. Among them, 
20patients had abnormal values; 15 Patients (30%) were found to have subclinical 
hypothyroidism and 5patients (10%) developed clinical Hypothyroidism. Out of 15 
patients who had subclinical hypothyroidism seven patients in one year follow up 
and three patients in 6months follow up .In clinical hypothyroidism out of 
5patients 4 were in one year follow up, one patient in 6months follow up.In 
concurrent chemo radiotherapy out of 35 patients 18 had hypothyroidism 
(51.42%)and in only radiotherapy 2 out of 15patients had hypothyroidism 
(13.33%),with P value of 0.0137 
 
 
  
Conclusion:  Thyroid dysfunction usually Hypothyroidism either Clinical or 
subclinical is a less recognized morbidity of external beam radiotherapy to head& 
neck exceeding the 40Gy radiation. Detecting hypothyroidism early and treating is 
preventing   associated complications. Hence mandatory to made  Thyroid function 
tests as a routine   during follow up. 
 
 
KEY WORDS: 
Head& neck cancer,  concurrent chemo radiotherapy, hypothyroidism, 
Radiotherapy.  
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1. INTRODUCTION 
 
 Thyroid gland is an endocrine gland which is located in anterior 
neck in front of trachea. It secretes two main hormones  
 
1. T3 (Tri iodothyronin) 
2.  T4 (Thyroxin), 
 
Essential  for normal growth and development. 
 
 The head cancers incidence fifth ranked in all other malignancies 
in Indian population probably due to tobacco use  in various forms
(1)
.The 
treatment modality for the  head & neck cancers are  
 
o Surgery 
o Radiation (RT) 
o Chemotherapy(CT) 
o Combination of these.  
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 RT, besides surgery the  only curative option,  in the treatment  
of patients with head and neck cancer. Radiation to thyroid gland in 
radiation field leads to Hypothyroidism. Most of head and neck cancers 
were  loco regionally advanced at diagnosis so we need to cover whole 
neck bilaterally along with the primary with adequate margins, to avoid 
missing neck nodes in the radiation field. 
 
 While on whole neck radiation thyroid gland in the neck which is 
close to head and neck primary sites also included in the field gets 
irradiated. This is an unavoidable normal tissue complication of external 
beam irradiation to neck. 
 
 Even though this thyroid dysfunction is unavoidable, it can be 
treated if we found early and morbidity can be avoided. The commonest 
late effect of thyroid gland radiation in patients exposed to therapeutic 
neck radiation (>40GY) is Hypothyroidism
2
. 
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Clinical Hypothyroidism characterized by high TSH values and low 
Free T4 and Free T3 values. 
 
Subclinical Hypothyroidism (Biochemical or compensated 
hypothyroidism): characterized by high TSH and normal 
FreeT4,Free T3 values. 
 
 Subclinical hypothyroidism proceeds to clinical hypothyroidism at 
a rate of 5 to 20% per year
3
.Though hypothyroidism was associated with 
significant morbidity,   performing thyroid dysfunction is not yet part of  
follow up of patients even in long-term survivors  of head and neck 
cancer. It resulted in failure to detect and treat a reversible cause of 
morbidity for those  patients. Nowadays with the practice of concurrent 
chemo radiation increases the loco regional control and increases the 
overall survival of patient whish increase the incidences of 
hypothyroidism. Hence the purpose our study to assess the incidence  
thyroid dysfunction in patients receiving neck irradiation, to assess the 
mean time for development of primary thyroid failure due to irradiation 
and to study the usefulness of thyroid function tests in follow-ups and 
make it as routine  follow up. 
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Evaluation of head &neck cancer treatment 
  The treatment of head and neck cancer are complex and it is 
difficult both technically and biologically. The sub sites of head and 
neck regions originate from the same squamous tissue. The clinical 
presentation and response to therapy differs for different subsites in 
addition structures of head and neck essentials for important functions 
body such as swallowing, breathing and speech. Hence organ 
preservation is important for selection of treatment for head and neck 
cancers. 
 
EPIDEMIOLOGY OF HEAD AND NECK CANCER: 
Worldwide the head and neck cancer incidence annually was more 
550,000 
4
 Males were affected  more than females with a ratio ranging 
from 2:1 to 4:1. The incidence rate in males exceeds 20 per 100,000 in 
regions of France, Hong Kong, the India,   Europe, Spain, Italy, Brazil 
and united states. 
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 The Indians are commonly affected with oral cavity cancers, the 
nasopharyngeal cancers are common in Hong Kong. 
 
Most of western population were affected with laryngeal and 
pharyngeal cancers, and accounts for 3%of malignancies (5).Among 
them 12,000 were dying of disease annually. 
 
Mouth and tongue cancers are more common in the Indian 
subcontinent, nasopharyngeal cancer is more common in Hong Kong, 
and pharyngeal and/or laryngeal cancers are more common in other 
populations. 
 
In the United States, head and neck cancer accounts for 3 percent 
of malignancies, with an estimated 55,000 Americans developing head 
and neck cancer annually and 12,000 dying from the disease
6
. The 
incidence of laryngeal cancer incidence was   50 percent higher in 
African American men
7
.The mortality associated laryngeal and or 
pharyngeal cancers higher in African American men, reflect the lower 
prevalence of HPV positivity
8
. 
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HEAD AND NECK CANCERS RISK FACTORS 
 
 SMOKING: It is a major risk factor for laryngeal cancers. 
Tobacco smoking contains more than 30 different types of 
carcinogen, such as polycyclic aromatic hydrocarbons and 
nitrosamines. 
40cigarette per day associated with 13times increased risk of cancer. 
And also patient continues smoke will have second cancers and field 
concretization  chances. 
 Alcohol 
 Tobacco chewing. 
 Human papilloma virus infection.  
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AIMS OF TREATMENT 
Curative treatment. 
Preservation of anatomy and function. 
Minimal sequlae of treatment. 
Best treatment delivery in cost effective manner. 
 
Modalities of treatment for locally advanced head and neck cancer 
 
 Surgery. 
 Radiotherapy. 
 Chemoradiation 
 Multimodality therapy. 
 
Majority of head& neck cancers locally advanced at diagnosis. 
Surgery and radiotherapy are the curative treatment options available. 
Each modalities of treatment have its own merits and demerits. 
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Radiation advantages:  
 No postoperative complication. Functional and cosmetic results 
maintained because no tissues removed. Surgical salvage of 
irradiation failure is probably more likely than the salvage of a 
surgical failure. 
 
The advantages of surgery includes 
Similar cure rates like Radiation and also the following: 
 Limited amount of tissue is exposed to treatment. 
 Shorter treatment time.  
 Radiation sequelae will be avoided. 
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CHEMOTHERAPY: 
Introduced later stage to prevent the development of second primary 
cancers (chemoprevention) 
 To palliate symptoms in patients with incurable disease 
 To improve the odds of cure or organ preservation when combined 
with definitive loco regional therapy. 
Toxicity vs  normal tissue complications in locally advanced head& 
neck cancer. 
 
The nonsurgical treatment modality for advanced head and neck 
cancer is concurrent chemo radiotherapy approach. 
 
It improves both loco regional and overall survivalfor patients with 
locally advanced head and neck cancer, IT CAN BE DELIVERED 
SYNCHRONOUSLY OR IN AN ALTERNATIVE REGIMEN. 
 
In modern era the concurrent chemo radiation is one of the 
treatment modality for locally advanced head and neck cancers for organ 
function preservation. 
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Advantages of concurrent chemo radiation: 
 
Maximize systemic therapy 
Radiation  enhancement 
Local  and systemic therapy delivered concurrently. 
 
 
Disadvantages 
 Increased toxicity 
 Increased  treatment  time. 
 Difficulty   in completing radiotherapy. 
 
The chemotherapeutic agent used to improve radiation effect and 
improve overall survival in head and neck cancers are the platinum 
group of drugs especially cisplatin. 
 
Concurrent chemo radiation 
 
1. The mechanism of interaction between these two modalities of 
treatment includes following: 
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2. The formation of toxic platinum intermediates with the in the 
radiation-induced free radicals, the capacity of cisplatin to 
scavenge free electrons formed by the interaction between 
radiation and DNA that may fixate otherwise reparable damage to 
DNA, a radiation-induced increase in cellular cisplatin uptake, 
 
3. Synergistic  effect between cisplatin and radiation because of cell 
cycle disruption. 
4. Inhibition  of repair of radiation-induced DNA lesions. 
It is radio sensitizing chemotherapeutic agent commonly used in 
head& neck cancer malignancies. 
 
Even though Cisplatin group drugs does not  cause thyroid 
dysfunction. Normal tissue complications of cisplatin effect on rapidly 
proliferating cells(mucosa and bone marrow) leads to mucositis and bone 
marrow depression. Thyroid is late responding tissue to radiation the 
effect on cisplatin in thyroid tissue not known. 
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Radiation therapy is one of the modality of treatment for patients 
affected with cancer. It is used as curative as well as palliative 
treatment. It was estimated that over 60% of patients with cancer will 
have radiotherapy as part of their total course of treatment
4
. 
 
Radiation therapy affects both tumor cells and uninvolved normal 
cells; the radiation therapy to the tumor benefit and to the normal tissue 
detriment of patients.  
 
In recent era of cancer care treatment With the goal of achieving 
high local regional control of cancer, balancing between the two (cancer 
cells as well as normal tissue) are  both an art and a science of radiation 
oncology. Unfortunately, after over 100 years of practicing radiation 
oncology and in spite of much recent progress,, knowledge on either of 
the two is far from perfect.  
 
Aims of radiation therapy  
 Better local tumor control. 
 Acceptable normal tissue complications. 
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2. HISTORICAL BACK GROUND 
 Wilhelm Conrad Roentgen discovered X-RAY in 1895.First 
medical use of X-Ray reported in lancet 23rd January, in 1896.(9). He 
publically demonstrated the clinical X rays radiograph on Swiss 
professor of anatomy Rudolf Albert von Kolliker ‘s wrist, using X ray 
beam(fig-1). 
 
Figure 1.first X Ray 
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 Leopold Freund an Australian surgeon who used x-ray for 
therapeutic purpose, he used for hairy mole-which disappeared after 
treatment. 
 In the year 1896 -Antoine Hentri Becquerel discovered 
Uranium-a radioactive material and invented radiobiological effect of 
radioactive material.(9) 
In the year 1898 -Pierre and Marie curie isolated polonium and 
radium, Pierre curie himself produced radium burn on his forearm on 
1901. Then radium used for 
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 EmilGrubbe,  a American medical student ( on 29th January 
1896)introduced radiation clinically. 
 
 EmilGrubbe, son of German couples , coined the term 
“radiotherapy” in 1903: 
 
“He was interested in comparing the effects of phototherapy and 
radiotherapy”10. 
After that the radiation oncology has developed 
 Radium was used for the radiation treatment purposes. 
 In a tissue-balance between cell birth and death to maintain 
tissue organization.  
 The response to cell damage- depends upon: 
 
 The inherent cellular radio sensitivity. 
 The kinetics of tissues 
 Ways cells are organized in tissues. 
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 The Fractions of cells are killed- cells lost their reproductive 
capacity. 
 If the radiation damaged   large amount of cells & killed and 
removed from the tissues. Radiation damage occurs on the dividing cells. 
 Radiation damage occur organs like bone marrow & intestinal 
epithelium Tissues with rapid cell turnover. Occasionally dividing cells 
like thyroid tissue, radiation damage remain latent for a long period and 
expressed very slowly. 
 
BERGONIE AND TRIBONDAUE
11
. 
The radio sensitivity depends on: 
 
 The poorly differentiated tissue 
 Cells with high mitotic activity.  
 Presence of more proliferated cells. 
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Bergonie and Tribondeaulaw, stated that  the effect of radiation on 
poorly differenciateddivided cells with high mitotic activity is high 
radiosensitive than 
 Well differentiated. 
 
From historical point of view, the first formal attempt to address to 
normal tissue tolerance radiation, was carried out by Rubin and 
Cassarett
12
..His publications helped radiation oncologist to buildup of 
normal tissue complications in future.  
 
In 1980s there was quantum leap of progress in  radiation 
oncology. With  monumental work of researchers on four National 
Cancer Institute multi-institutional contracts, the science and practice 
of radiation oncology Changed from a two-dimensional (2D) to a three-
dimensional (3D)/volumetric process. 
 
The work done by above studies, it became apparent to the 
clinicians that information on the tumoricidal doses of radiation as 
well as normal tissue complication doses, especially on partial 
volumes, is mostly empirical and totally inadequate. Finally the data 
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done by them were analyzed by committee addressed for that shows all 
the data were   not consistent. 
 
Moreover, in order to shed some light on the volumetric aspect of 
these issues, it was decided that organs be divided into one-third, two-
thirds, and whole organ volumes. In spite of the clear indication in the 
manuscript on the paucity of solid experimental/prospectively driven 
data, this publication, so-called Emami’s paper, has gained much 
popularity.  
 
The main goal of this publication was to address a clinical need 
based on available information up to that time and points to the fact that 
there is a need for extensive and comprehensive research in this area.  
Flaws of the publication: 
 
1. It was a literature review up to 1991. 
2. It was completely pre-dated the 3D-CRT, IMRT- IGRT era.Time 
dose-volume histograms - not in routine clinical use. 
3. This was a tabulation of the estimates for three of the 
aforementioned arbitrary volumes  
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4. This was for external beam radiation with conventional 
fractionation.  
5. Only one severe complication was chosen as an endpoint.  
 
Over the last two decades, since the publication of “Emami’s 
paper” the practice of radiation oncology has been completely 
revolutionized:  
 
 Multidisciplinary management of cancer -become the 
standard of care.  
 Choice of an endpoint for complication analysis and 
modeling has significantly altered.  
 
There has been a major revolutionary change in technology:  
 
CT simulation has become routine along with the fusion of other 
modalities such as MRI, PET, and 3DCT ,4DCRT/IMRT/IGRT has 
become standard with the array of evaluation tools.  
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As a result, dose distributions have become very complex and 
as of recent, the fourth dimension, namely time, has also been added to 
this complex. 
Multiplicity and complexities of factors affecting radiation 
including normal tissue complications have made it impossible to have 
actual data for every clinical situation facing practicing radiation 
oncologists. Therefore, there is a need for reasonable predictive models 
for plan evaluation, to improve tumor control, and to predict and 
hopefully prevent normal tissue injury.  
 
During the last two decades, a vast amount of published 
information has become available to address the relationship between 
dosimetric parameters and the clinical outcomes of normal tissues. 
Because of different analytic methodologies, calculation methods, 
endpoints, grading schemes, etc., the data is noisy and shifting through 
these data for practicing radiation oncologists is a nearly impossible task.  
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Realizing this difficulty and the obvious need for a simplistic 
format, a group of physicians and researchers were formed with the 
name “The Quantitative Analysis of Normal Tissue Effects in the 
Clinic (QUANTEC).”  
 
 
The first goal was to review the available literature of the last 18 
years on volumetric /dosimetric information of normal tissue 
complication and provide a simple set of data base to be used by busy 
community practitioners of radiation oncology. 
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RADIATION EFFECTS 
 
 
Fig-3 Radiation effect 
DOSE RESPONSE RELATIONSHIP OF NORMAL TISSUE AND 
TUMOR  
Radiobiology applied to clinical radiotherapy applied to clinical 
radiotherapy concerned with relationship between given absorbed dose 
24 
 
and consequent biological responses normal tissue as well as tumor 
tissue. 
 
ABSORBED DOSE: 
Defined as energy  imparted per unit mass by ionizing radiation to 
the matter at a specific point. 
 
ABSORBED DOSE:JOULE/KG OR GRAY.(13) 
Radiation effect is directly proportional to radiation dose, 
increasing radiation will cause increase in grade and incidence of effect. 
so the relationship between dose and response of tissues are plotted in 
graph is called dose response curve. This curve is sigmoid shape. 
 
The dose response effect otherwise called as TCP(Tumor control 
probability), applies to both tumor control and normal tissue 
complications. 
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TCP : GRAPHICAL REPRESENTATION
14
. 
 
Figure-4.TCP Vs NCTP 
 
THERAPEUTIC  INDEX
15
. 
The ratio of tumor response for a fixed level of normal tissue 
damage called as therapeutic ratio or therapeutic index. This graph 
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denotes 30% probability of tumor control with 5%incidence of normal 
tissue complication. 
 
NORMAL TISSUE COMPLICATION AND TIME FACTOR: 
Time factor is one of important factor for increasing and 
decreasing therapeutic ratio. For example. 
 
Hyper fractionation: 
 
This Cause more acute side effects and sparing late responding 
normal tissues than tumor control, especially thyroid gland like tissues. 
In TCP curve the addition drug or radio sensitizer will increases the 
tumor control with less normal tissue complications, this will increases 
the therapeutic gain. The addition drug move the TCP curve to left father 
away from normal tissue. This denotes the drug has a greater tumor 
control with less normal tissue complications. 
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For example cisplatin use in head &neck cancer have the same 
effect, but synergistic effects of radiation cisplatin radio sensitizer effect 
increase the acute toxicity. So in summary the normal tissue 
complications determined by radiation dose, duration of treatment time,  
andthe fractionation schedule. 
 
Normal tissue effects of radiation: 
 Acute effects 
 Late effects. 
 
Both the above effects in normal tissue caused by cell killing by: 
 Release of inflammatory cytokines. 
 Depletion of normal tissue population. 
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TOLERANT DOSE FOR DIFFERENT ORGANS 
Organ 
TD 
5/5 
    
TD 
50/5 
    
  Whole 2/3 1/3 Whole 2/3 1/3 
Bladder 6500 8000 N/A 8000 8500 N/A 
Brachial plexus 6000 6100 6200 7500 7600 7700 
Brain 4500 5000 6000 6000 6500 7500 
Brainstem 5000 5300 6000 6500 – – 
Optic nerve 5000 – – 6500 – – 
Parotid gland 3200 3200 – 4600 4600   
Rectum 
(severe 
proctitis,necrosis,fistula,stenosis) 
6000 – – 8000 – – 
Spinal cord 
(20 
cm) 
4700 
(10 
cm) 
5000 
(5 
cm) 
5000 
– 
(10 
cm) 
7000 
(5 
cm) 
7000 
TMJ mandible 6000 6000 6500 7200 7200 7700 
Thyroid 4500     8000     
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The tolerance dose- dependent on 
 
 Total dose 
 Fractionation schedule 
 Volume of irradiated normal tissue  
 
 TD 5/5 = 5%   (probability of severe sequelae in 5 years) 
 
 TD 50/5= 50% (probability of severe sequelae in 5 years) 
 
Thyroid gland 
The thyroid gland develops from median outgrowth from the floor 
of the pharynx near the base of the tongue. The foramen caecum of the 
tongue indicates the site of origin and the thyroglossal duct marks the 
path of migration of the thyroid gland to its final adult location. 
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Anatomy  
Both thyroid and parathyroid glands are endocrine glands positioned 
anteriorly in the neck.  
 
The thyroid gland is a large, unpaired gland. It is lying deep to the strap 
muscles. Laterally both sides condensation of deep cervical fascia is 
namely Berry’s ligament. 
 
Blood supply  
 Superior thyroid artery:The first branch of the external carotid 
artery. It divides into anterior and posterior glandular branches:  
Anterior glandular branch supplies along the superior border of the 
thyroid gland and anastomoses with its twin from the opposite side 
across the isthmus;  
 
 Posterior glandular branch passes to the posterior side of the 
gland and may anastomose with the inferior thyroid artery. 
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Inferior thyroid artery  
 The inferior thyroid artery is a branch of the thyrocervical 
trunk, which arises from the first part of the subclavian artery. 
At the thyroid gland the inferior thyroid artery divides into an:  
 Inferior branch, which supplies the lower part of the thyroid 
gland and anastomoses with the posterior branch of the superior 
thyroid artery;  
 An ascending branch, which supplies the parathyroid glands.  
 
Thyroid ima artery  
 Occasionally, a small thyroid ima artery arises from the 
brachiocephalic trunk or the arch of the aorta and ascends on the anterior 
surface of the trachea to supply the thyroid gland.  
 
 
 
 
 
 
 
32 
 
 
Venous drainage 
 
Superior thyroid veins - drains into the internal jugular vein. 
Middle thyroid veins - drains into the internal jugular vein 
Inferior thyroid vein(lt) - terminate at the left brachiocephalic  
     vein.  
Inferior thyroid veins(Rt) - drains into the right brachiocephalic  
     vein. 
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Fig-5 Thyroid anatomy 
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Fig-6 Thyroid anatomy 
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Formation of thyroide hormones 
 
Thyroid Hormones
- tetraiodothyronine- (thyroxine)
- triiodothyronine (T3)
 
 
Production of Thyroglobulin 
 
• TSH, which binds to follicle cell receptors- produce thyroglobulin 
(glycoprotein). 
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Thyroid Hormone Synthesis
 
Fig-7 Thyroid hormones metabolism 
 
Transport of Thyroid Hormones. 
 
 Thyroid Hormone-Binding Globulin (~70% of hormone) 
 Pre-albumin (transthyretin), (~15%) 
 Albumin (~15%) 
37 
 
The Thyroid Gland – Histology
.
Squamous epithelial cells, cuboidal cells (follicle cells)
I
 
Fig-8-. Thyroid gland  histology 
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Fig-9. Thyroid histology 
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Fig-10. Thyroid hormones metabolic effects. 
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Fig-11. Cervical nodes-Levels. 
 
Level I- Submental and submandibular nodes. 
Level II- Uppper jugular nodes. 
Level III-Mid jugular nodes. 
Level IV-Lower jugular nodes. 
Level V-Posterior triangle and SClnodes. 
Level VI-Anterior compartment neck nodes. 
Level VII-Superiormediastinal nodes. 
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Thyroid cellular biology: 
 
 Hypothyroidism or hyperthyroidism can develop after 
radiotherapy especially hypothyroidism. Hyperthyroidism results from 
Grave's disease or thyroiditis and the latter usually results in subsequent 
hypothyroidism. The manifestations of hypothyroidism are outlined in 
the preceding section. Hyperthyroidism is characterized by heat 
intolerance, weight loss, insomnia, increased appetite, diarrhea, moist 
skin, tachycardia, nervousness, tremors, exophthalmos, and goiter. 
Thyroid enlargement, and more frequently, thyroid nodularity, can also 
develop. 
 
 Time Course of Events: The time course of developing late 
thyroid effects is highly variable. The risk for both hypo- or 
hyperthyroidism reported in one study increased in the first 3 to 5 
years since diagnosis, whereas the risk for nodules increased at 10 
years from diagnosis. 
 
 Dose/Time/Volume: Hypo- or hyperthyroidism results from 
fractionated radiation >20 Gy to the neck or cervical spine, or >7.5 
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Gy of TBI. Thyroid nodularity can occur after lower dose 
exposures. Recent data on patients with head and neck cancer 
support a radiation dose-response for hypothyroidism. 
 
 Chemical/Biologic Modifiers: In children treated for Hodgkin's 
disease, the addition of chemotherapy to radiation does not appear 
to increase the risk of hypothyroidism, although chemotherapy 
alone can result in hypothyroidism. 
 
 Radiologic Imaging: Thyroid nodules should be assessed by 
ultrasound, and an I-125 scan can be considered. 
 
 Laboratory tests: Free T4 and TSH should be used to monitor 
thyroid function. 
 
 Differential Diagnosis: Grave's disease, Hashimoto's thyroiditis, 
and idiopathic thyroid nodules can occur in the general population. 
Patients undergoing cranial irradiation may have neuroendocrine 
deficiencies (namely TRH deficiency) as previously discussed. 
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 Pathologic Diagnosis: Fine-needle aspiration of newly diagnosed 
thyroid nodules, particularly those that do not demonstrate I-125 
uptake, is suggested. Suspicious nodules or biopsy-proven thyroid 
cancer should be resected. Interpretation of the fine-needle 
aspiration may be confounded by radiation-induced atypia. 
 
 Management: Thyroid shielding during therapeutic radiation 
should be considered if possible to lower the risk of late thyroid toxicity. 
Hypothyroidism can be managed with thyroxin replacement, and 
hyperthyroidism can be managed with propylthiouracil (PTU), propanol 
I-131, or thyroidectomy. Thyroid nodules should be managed as 
previously described. 
 Follow-up: Routine examination of the neck should be performed 
to assess for nodularity and/or growth. The NCI recommends 
annual laboratory assessment up to 10 years post radiation 
The reason for hypothyroidism common in Females in general 
population:  
 .In females estrogen(estradiol) effect on thyroid hormone 
functioning by antagonizing or competing the binding sites 
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for T4 and T3.If the estradiol finds first to thyroid hormone 
receptor it will suppress thyroid hormone secretion and leads 
to hypothyroidism. 
 Estradiol also limits the thermogenic activity of thyroid 
stimulating hormone (TSH), their by reduces the muscular 
activity and increase the fat deposition in females. 
 
 The another mechanism why females has the tendency to 
have hypothyroidism is by Autoimmune disorder, so female 
has more prone for autoimmune disease their by destroying 
thyroid gland leads to its deficient activity.    
 
 Females eat very less, their calorie intake is very low 
compared to men ,less fat consumption leads to decreased 
productionhormones 
suchas,cortisol,aldossterone,progesterone,estradiol,testostero
ne,etc. Likewise less protein intake leads to decreased peptide 
hormone production like thyroid hormones .So adequate fat 
and protein intakes also essential for our body hormones 
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secretion. Thyroid hormones consist of the amino acid 
tyrosine combined with 1, 2, 3, or 4 atoms of iodine (hence, 
they have names such as tri – iodo- thyronine). 
 Some food items especially soy foods are goitrogenic. 
 More stress leads to hypothyroidism by decreased thyroid 
hormone secretion. 
 Finally the cause may be idiopathic. 
 
The reason for hypothyroidism common in neck irradiated female 
patients:  
1.Autoimmunity:   
 Radiation induced hypothyroidism is a organ specific autoimmune 
disorder, causing epithelial damage as well as necrotizing vacuities and 
thrombosis. Injury to the epithelial tissue leads to release of thyroid 
cellular components that acts as a triggering antigenic stimulus leads to 
production of organ specific Auto antibodies and leads to initiation of 
autoimmune process and thyroid dysfunction.  
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 In autoimmune mechanism their must by sustain release of auto 
antibody following antigenic stimuli a genetic susceptibility must be 
present. 
 
 In females it is present in Ir-1 lies within the majority 
histocompatibility complex. 
 
 In males it is HLA-8 association has been demonstrated for 
autoimmune mechanism. 
 
 Tamura et al demonstrated raised antibody titer following 
irradiation then they subsequently become hypothyroid. 
 
2. Vascular damage:  Leads to necrotizing vacuities and thrombosis. 
 
3.Parenchymal damage: 
 Leads to thyroid dysfunction by epithelial injury and destruction 
of parenchyma. 
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3. Review of literature 
 
 Impact of RT on thyroid function was first reported in 1929
1
. 
There is no clear cut data is not available for post RT thyroid failure. 
Most of the reports on thyroid disorders following  RT are mostly 
retrospective. This lacks pre vs. post irradiation evaluation that  includes  
small patient populations. Long term follow-up is not available even in 
long term survivors.
16,17. 
 
 Most of cases were proceeded from subclinical hypothyroidism  to 
clinical hypothyroidism
5
. Subclinical hypothyroidism progressed to 
clinical hypothyroidism occurs at a rate of about 5 to 20% per year. 
 
 Complication of \subclinical hypothyroidism were less well 
established and  most of the literature estated  that  adverse consequences 
such as cardiac dysfunction and other subclinical hypothyroid symptoms  
progress to clinical hypothyroidism
18,19
. Thyroxin supplementation 
improves cardiac function in subjects with subclinical hypothyroidism. 
 
 High magnitude and duration of increased TSH,  increase the 
probability of progression to clinical hypothyroidism. Hence diagnosing 
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and treating the patient  with subclinical hypothyroidism, potentially 
benefits the patient. 
 
 Detecting subclinical hypothyroidism at an early stage  will 
preventclinical hypothyroidism  also its morbidity
20
. 
 
 FELIX and MERHERSON -s1960s reported the development of 
hypothyroidism after RT for head & neckmalignancies
21,22
. Incidences 
of  hypothyroidism following  RT were between 3 to 47.Thyroid 
dysfunction occurs within months to years after external beam 
radiotherapy to neck.%. An incidence of 20 to 30% has been reported 
by most investigators
23 
 
 The study with the longest follow-up studied by Einhorn and 
Wikholm. With 10-year follow-up of 41 patients of  Ca -larynx and 
Ca-hypo pharynx, treated with RTand found  the incidence  of 
hypothyroidism was 7.3%
24
. 
 
 Glatsteinet al. published the  high incidence of  primary thyroid 
failure  in patients who were  treated with radiation  for Hodgkin's 
disease and malignant lymphoma
15 
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 Alterioet al. mentioned radiation-induced late effects, especially  
thyroid disorders are underestimated. Primary hypothyroidism was the 
most frequent late effect with an incidence of 20 to 30%
16
. 
 
 Emamiet al. reported -tolerance values of 8/5, 13/5, and 35/5 
(incidence of clinical hypothyroidism in 8%, 13%, and 35% of patients 
at 5 years) at the level of 45, 60, and 70 Gyrespectively
25
. 
 
 Srikanth etalreported mean age  was  60 years. Men were  
highermean age (58.78 years) as compared with women (52.13 years).  
These patient characteristics were same as published by Tell R et al 
andAich  RK et al.Most of  the cancers were  Ca-hypopharnx(36.5%). 
Aich had a higher percentage of cancers arising fromthe larynx 
(49%).All the patientsreceived whole-neck irradiation and hence the 
primary site of the tumor was not a significant factoruniformity in the 
volume of thyroid irradiated.. 
 
 Aich  showed  21% incidence with concurrent chemoRT as 
compared with16.6% with RT  only. 
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4. AIM OF THE STUDY 
 
 The incidence of Hypothyroidism, 
 The time to required become hypothyroid 
 Dose of RT related with development of hypothyroidism 
 And whether there any patient related and treatment related factors 
that are predictive for the development of hypothyroidism 
 The use of concurrent CT &RT(whole neck radiation) patient or 
only using RT being assed for development of hypothyroidism. 
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4. MATERIALS AND METHODS 
 
 Fifty patients with head & neck malignancies receiving whole 
neck irradiation were included in this study compared with 25 breast 
patients receiving radiation to chest wall and Breast only. Thyroid 
function tests (TFT) are done at baseline, (before Radiation, concurrent 
CT/RT) at 6 months and 12 months  intervals. 
 
The cases includes patients with locally advanced malignancies of  
 
1. Nasopharynx. 
2. Hypopharynx. 
3. Oropharynx. 
4. Oral cavity- which needs whole neck radiation. 
5. Larynx. 
 
The controls includes: 
 
1. Patients receiving irradiation for breast cancers(Excluding neck). 
 These patients are selected and thyroid function test was done using 
CLIA(Chemiluminenceimmunoassay) technique, at 0,6,12 months 
interval. Results were observed for cases and controls, and statistical 
significance was Assed using FISHCER EXACT TEST-, 
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FISHER EXACT TEST 
 Class-I Class-II Total 
Sample 1 A B a+b 
Sample 2 C D c+d 
Total a+c b+d N 
 
 If there were no systematic association between the variables A 
and B the population from which the cell frequencies are randomly 
drawn, the probability of any particular possible array of cell 
frequencies, a,b,c,d given fixed  values for the for the marginal totals 
a+b+c+detc, would be given by hyper geometric rule 
 
P(outcome
) 
= 
(a+b)! (c+d)! (a+c)! 
(b+d)! 
 
N! a! b! c! d! 
 
In performing factorial 
operations 
recall that 0!=1 and 1!=1. 
 
 
  
 Also the degree of disproportion with any array of cell 
frequencies-in effect, the degree of ostensible association between 
variables A and B within the sample-canbe measured by absolute 
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difference. 
 Two tailed probability would be that sum plus the sum of the 
separate probabilities for the arrays of equal or greater disproportion at 
the other extreme. 
 
 
Head & neck arm : 
 
Immobilization  is done with the help of Thermoplastic Head & 
Neck mould(fig-2). All the patients are made to undergo CT scans (5mm 
cuts) starting from vertex to carinal region.  
 
 
Figure 12.Immoblization & for head&neck CA. 
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 For all head and neck patients immobilization done with the help 
of thermoplastic head and neck mold ,the purpose of immobilization are 
patient reproducibility and correct dose delivered to tumor and avoiding 
normal tissue complications. 
 
The data sets are then transferred to TPS and the dose to target and 
Thyroid  are then determined. Those patients whose receive <40Gy to 
thyroid are excluded from the study. 
 
 
Figure-13.contouring for target & thyroid 
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 This is the picturing showing PTV(planning target volume) for 
patient affected with hypo pharynx cancer .The PTV includes the 
primary and bilateral neck nodes. 
 
DOSE VOLUME HISTOGRAM  
 
 
Figure-14.DVH HEAD& NECK 
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 Dosevolume histogram is angraphicalrepresentation  
providesquatitative information with regard to how much dose is 
absorbed in how much volume of tissue.It also summarise entire 
dose distribution into a  single curve for each anatomical structure 
of interest. 
 
TYPES 
1. Cumulative interagral DVH. 
2. Differencial  DVH. 
 
Breast arm: 
Immobilisation   done with the help of thermoplastic breast mould.  
 
 
Figure-15.Breast  immobilization 
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 Picture showing patient immobilized with thermoplastic breast 
mould with breast board. Patients are made to undergo CT scans( 5mm 
cuts) starting from neck to upper abdomen. The data then transferred to 
the treatment planning system and dose to target determined. 
 
 
 
Fig-16. Breast contouring. 
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 This shows planning target volume patient with breast cancer, The 
PTV includes primary with margin. 
 
 
. 
Fig-17. Breast dose volume histogram 
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Detection of hypothyroidism (sub clinical or clinical)-as primary end 
point of survey. 
 
 Patients who are detected to have hypothyroidism(sub clinical or 
clinical), after external beam radiotherapy are made to be reviewed by 
Endocrinologist and appropriate supplementation with Thyroxin was 
done. 
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INCLUSION CRITERIA 
 
1. Baseline TFT should be normal. 
2. Patients should receive whole neck irradiation with or without 
chemotherapy was taken as one arm. 
3. Patients receiving irradiation for breast cancers(Excluding neck), 
was taken as control arm. 
4. All ages and both the sexes are included. 
 
EXCLSION CRITERIA 
   
1. Patients with previous thyroid surgeries. 
2. Previous irradiation to neck region. 
3. Previous thyroid diseases. 
4. Recurrent  thyroid diseases. 
5. Dose to thyroid < 40Gy. 
6. Baseline thyroid dysfunction 
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STUDY DESIGN 
 
      Prospective case control study. 
 
STUDY PERIOD 
 
        September’2013 to November’2014. 
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6. Results of the study 
In our Single institution, Prospective case control study 
From Head & neck, 50 patients were selected as per the inclusion 
criteria in study arm, and 25 patients with breast carcinoma were 
selected as per the inclusion criteria in control group.  
 
The TFT was taken 0  , 6, 12 months interval. 
 
Thyroid dysfunction (either clinical or subclinical) was taken as 
primary end point and patients were treated with appropriate dose of 
Thyroxin as per the Endocrinologist opinion. 
 
The results of the study was detected and analyzed with various 
factors such as Age, Sex and dosimetry and statistical analysis was done 
using EXACT FISCHER TEST. 
In our study we found some patients having neuropsychiatric 
symptoms such as depression, irritability which was mostly neglected by 
the relatives and these patients underwent evaluation of thyroid function. 
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By this study, we like to ensure that all subclinical hypothyroidism 
patients are needed to be supplemented with oral Thyroxin to prevent 
progression to clinical hypothyroidism and its consequences, as a 
primary prevention.  
 
 In our study we took 50 patients who were underwent whole neck 
RT, as a treatment for head & neck malignancy. 
 
Patient characteristics 
Total patients studied  :   75 
Head& neck     :   50  
Breast            :    25 
Sex   distribution 
Sex Head& neck    Breast 
Male  39 0 
Female  11 25 
 
Table-1. Sex distribution 
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 Thyroid dysfunction is most common in general population with 
the percentage of 0.02%. 
  
Irradiation of head &neck primary includes thyroid gland in 
radiation field leads to unavoidable radiation effect due close proximity 
of thyroid gland to head & neck primaries, leads to thyroid dysfunction 
and its long term consequences. 
 
Most of literature reviews quoted that thyroid dysfunction 
especially hypothyroidism occurs at an earlier stage that is 6 weeks after 
radiation to 3 to 5yrs .In our study we found out thyroid derangement in 
6 and 12 months post RT to neck. 
 
Head and neck cancers are male preponderance, hence 39 male 
patients and 11 female patients fall in our study . 
 
In our Study - Post RT head & neck arm 40% of patients 
developed hypothyroid.  Females  were affected almost all patients (10 
out of 11)  ,  
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In control arm the post RT – breast, all pts are females and no 
males were taken because of low incidence of male CA Breast. But 
without the neck RT,  none developed hypothyroid in the breast Ca 
control group.   
 
So irradiation to neck includes thyroid gland in field leads to 
irradiation of thyroid gland which receives radiation dose above the 
threshold level leads to thyroid dysfunction which is the late irreversible 
normal tissue complication of radiation effect.  
 
This signifies the importance of routine screening of TFT in all 
patients receiving neck irradiation. But the females has a tendency to 
become hypothyroid early than males, where the hypothyroid was 
developed at little slower rate and low percent compared with females, 
with statistical significance, in our study.  
 
In our study we recommend to screen all the patients who received 
the neck radiation with TFT 6, 12 monthly intervals with  baseline 
Thyroid Function Test. 
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Demographic data 
In our study, on evaluation  results were found to be 40 % patients 
had developed hypothyroidism, among this 10 % were clinical, as well 
as none developed in the control breast arm.  
 Hypothyroidism Normal thyroid Total pts 
Head&neckCa 20 30 50 
Breast  Ca 0 25 25 
 
Table -2.Incidence of hypothyroidism. 
P value <0.0001 (0.000067). P value signifies that hypothyroidism 
strongly associated with head & neck RT. 
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Figure – 18 
This bar diagram showed the statistical significant noted that 
head & neck RT is strongly   associated with development of 
hypothyroidism. 
 
 
 
68 
 
Sex distribution for the head and neck  arm 
SEX  
DISTRIBUTION 
SUBCINICAL  
HYPOTHYROID 
CLINICAL  
HYPOTHYROID 
NO 
HYPOTHYROID 
TOTAL 
MALES 9 1 29 39 
FEMALES 6 4 1 11 
TOTAL 15 5 30 50 
 
Table-4 .Sex distribution for the head and neck  group 
P <0.001(P=0.000152). It signifies that the females were strongly 
associated with developement of hypothyroidism. 
 
Sex distribution for the Breast arm 
SEX  
DISTRIBUTION 
SUBCINICAL  
HYPOTHYROID 
CLINICAL  
HYPOTHYROID 
NO 
HYPOTHYROID 
TOTAL 
MALES 0 0 0 0 
FEMALES 25 0 25 25 
TOTAL 25 0 25 25 
 
Table-5. Sex distribution for the Breast arm 
69 
 
In our study, among 50 patients 39 were males represents 78% and 
11 were females represents 22%. In Breast arm 100% females are taken 
for our study. 
 
And 20 out of 50 patients in head and neck arm found to have 
hypothyroidism which represents 40%.Among this 2/3 are sub clinical 
and 1/3 patients are clinical hypothyroid. 
 
And breast arm, all female patients  developed neither subclinical  
hypothyroid nor clinical hypothyroid. And in our study found that the 
strong statistical association noted in irradiated  females who were 
developed  hypothyroidism than their male counterpart. 
 
In sex ratio analysis out of 50 patients 20found to have 
hypothyroid, among them in males 10 out of 39 found to be hypothyroid 
and in females 10 out of 11 found to be hypothyroid, this shows more 
female preponderance. In general population the incidence 
hypothyroidism in general population is 0.02% per year(27)which also 
has the female sex has a preponderance.. 
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figure-17 .Sex distribution for the head and neck  group
Sex distribution for the head and neck  group
males
females
 
In the Bar diagram, we notice the subclinical thyroid was 
proceeded by the clinical illness. 
 
Females were affected by subclinical at an earlier stage then 
proceeded to clinical hypothyroid in a descending order. Also detected 
that almost all female  needsthyroxine supplementation at 6- 12 month 
interval. 
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 Males also significantly had thyroid dysfunction, but  head&neck 
cancer incidence are more common in male population. In this study 
showed  the incidence is less comparable to males than females. We also 
found that  thyroid dysfunction developed  at the last quarter of year. 
 
So this sex ratio incidence of thyroid dysfunction denotes 
screening for thyroid in patients of neck irradiation is mandatory in  
earlier and at regular intervals for long term survivors of locally 
advanced head& neck cancer. 
Age distribution. 
The table shows the age was subdivided into 4 category . 
AGE 
DISTRIBUTION 
SUBCINICAL  
HYPOTHYROID 
CLINICAL  
HYPOTHYROID 
NO 
HYPOTHYROID 
TOTAL 
20-35 0 0 3 3 
36-50 4 2 0 6 
51-65 11 3 19 33 
>66 0 0 8 8 
T0TAL 15 5 30 50 
 
Table-3.age distribution 
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In our study the age groups of patients studied between 20 to 
>66yrs of age with the mean age for males were 52yrs, and the females 
were 59yrs. 
The incidence of hypothyroidism was 14 out of 20 were in the age 
group of 51-65 yrs of age group, and 6 out 6 in the age group of 36-50 
yrs age. This analysis showed the incidence of hypothyroidism is 
common in elderly and young age group. 
The study done by Bonato and colleagues’ showed the incidence 
of hypothyroidism in the childhood survivors who received radiotherapy 
to neck.(13) 
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This is due to radio sensitivity of thyroid tissue decreases with the age. 
In our study we found that the radio sensitivity was inversely 
proportional to the age. None of the aged above 66 developed 
hypothyroidism. 
 
The another study Colevas et al stated the increase incidence of 
hypothyroidism in patients in 60yrs of age group.(14) 
 
 In our study showed the incidence of hypothyroidism is higher in 
young as well as elderly age groups. 
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Chemo RT Vs only RT 
 SUBCINICAL  
HYPOTHYROID 
CLINICAL  
HYPOTHYROID 
NO 
HYPOTHYROID 
TOTAL 
CONCURRENT  
CT/RT 
13 5 17 35 
ONLY RT 2 0 13 15 
 15 5 30 50 
 
Table-4 chemo RT Vs RT only 
 
Out 50patients studied 35 patients received concurrent 
chemoradiation and 15 received only radiotherapy. Among 35 in 
concurrent CT+RT group 18 had hypothyroidism. 
 
Only RT group 2 out of 15 had hypothyroidism. 
In patients received concurrent CT/RT 51.42 % pts developed 
hypothyroidism,and patients received only  RT developed 13.33 % .  
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In the bar diagram : Concurrent chemo radiation group had more 
hypothyroidism compared   to only  radiation therapy group. 
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In our study group concurrent chemo radiation group received 
cisplatin based chemotherapy along with RT. 
 
Cisplatin: It is radio sensitizing chemotherapeutic agent 
commonly used in head neck& cancer malignancies. 
 
Even though Cisplatin group drugs does not  cause thyroid 
dysfunction.Normal tissue complications of cisplatin effect on rapidly 
proliferating cells(mucosa and bone marrow) leads to mucositis and bone 
marrow depression. Thyroid is late responding tissue its effect on 
cisplatin is not known. In our study group population hypothyroidism 
more in chemo RT group, the cause for this is not known, should be 
studied in  future . 
 
The impact of adjuvant chemotherapy treatment on the risk of 
development of hypothyroidism in head &neck malignancies is studied 
by both Kanti(15)  et al and Sinrad (16)et al found that no effect of 
chemotherapy in thyroid gland dysfunction. 
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SITE OF PRIMARY TUMOR          
SITE OF PRIMARY 
TUMOR 
 
SUBCINICAL  
HYPOTHYROID 
CLINICAL  
HYPOTHYROID 
NO 
HYPOTHYROID 
TOTAL 
SUPRAGLOTIC
LAlRYNX 
1 0 7 8 
NASOPHARYNX 1 1 1 3 
ANT2/3TONGUE 3 0 7 10 
OROPARYNX 1 1 5 7 
HYPOPHARYNX 9 3 10 22 
TOTAL 15 5 30 50 
 
Table-5 . Occurrence  of  hypothyroidism with site of primary. 
In our study, 50 patients analyzed and found the hypoparynx 
malignancy had 12 of 22 patients had hypothyroidism.  Followed by 
Nasopharynx out of 3patients 2 had hypothyroidism, and anterior 2/3 of 
tongue patients 10 out of 3 had hypothyroidism. 
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 But in our all patients included received whole neck irradiation, 
so there is primary site is not a risk factor for hypothyroidism. In our 
study showed 12 patients (24%) developed noted hypothyroidism, The 
primary site of involvement is varied in literature. 
 
Here in this study primary site of tumor was not a significant 
factor for developing hypothyroidism, because all the patients made to 
undergo whole neck irradiation. The  exposure of RT to  thyroid a  was  
equal in all head& neck cancers , hence we unable to find  difference  
according to the primary site of tumor. 
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In this bar diagram, we can see those lines were parallel. 
Hence we come to the conclusion that whenever the frequency 
was increased  the incidence of hypothyroidism was increasing. 
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RADIATION DOSE: 
 
The thyroid gland tolerance dose TD5/5 is 20GY when part or 
whole thyroid gland irradiated with conventional fractionation. 
 
TD 5/5 : Defined as the radiation dose that could cause not more 
than 5% severe complication rate within 5yeary is after treatment. 
 
In our study we included 50 patients, all the patients received 
radical dose to the neck that is 60-66gy. 38(76%) patients received 60gy 
RT, 12(24%) received 66gy RT, by conformal technique. 
 
The mean dose thyroid gland irradiation is 59GY.Which is more 
than tolerant dose of thyroid gland leads to its ablation and causing 
hypothyroidism. The mean dose thyroid gland irradiation is 
59GY.Which is more than tolerant dose of thyroid gland leads to its 
ablation and causing hypothyroidism. 
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ONSET OF HYPOTHYROIDISM  
 
In our study we conducted for one year duration, we found out 
20(40%) patients developed hypothyroidism following RT to neck. 
Among them 12% had subclinical hypothyroidism at6months ,18%had 
subclinical hypothyroidism at one year.In clinical hypothyroidism 4(8%) 
had at one year.1patient (2%) had hypothyroidism at 6months post RT. 
 
 SUBCLINICAL 
HYPOTHYROID 
CLINICAL 
HYPOTHYROID 
6MONTHS  6 1 
1YEAR   9 4 
TOTAL  15 5 
 
Table-6.Onset of hypothyroidism with occurrence of hypothyroidism. 
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We also found that the subclinical and earlier presentation occurs 
in female gender rather than male. By this study we able to prevent the 
occurrence  of clinical hypothyroidism. 
 
 
 
 
83 
 
In this diagram, subclinical to  clinical  manifestation developed 
over a period from 6 months to 1 year.This graph represents the patients 
affected with subclinical hypothyroidism is more than clinical 
hypothyroidism in 6months post irradiation, but the clinical 
hypothyroidism will be more in 1year followup.This shows the 
progression of subclinical to clinical hypothyroidism is more in one year 
follow up. 
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7. DISCUSSION 
 
The effects  of ionizing radiation on thyroid gland in therapeutic 
neck irradiation (40-70GY) leads to hypothyroidism. The impact of post 
irradiation hypothyroidism first reported in 1929
1
.The first reported case 
of hypothyroidism in patients treated for head &neck malignancy 
reported in literature on 1961
(16) 
 
Most of literature review quoted that the incidence of  
hypothyroidism following  RT have ranged from 3 to 47%. Most of the 
studies states that the incidence is between 20 to 30% .(17). 
 
In our study shows 40% incidnce of hypothyroidism comparable 
with literature reported above. 
 
In our study we detected the incidence of hypothyroidism in cases 
40% and controls 0%,. 
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Among 40%,the subclinical hypothyroidism is 30% and the 
clinical hypothyroidism is 10%, but in control arm none of the patient 
had hypothyroidism,  
 
which clearly states that the radiation to the neck and radiation dose 
are the risk factor for causing hypothyroidism 
The following studies shows the incidence of hypothyroidism. 
 
1. 1.Study done by Einhorn and Wikhokins ,for the periods of 
10yrs of follow-up in 45pts  treated with radiation for carcinoma 
of larynx and hypo pharynx, they evaluated the incidence of 
hypothyroidism is 7.3%.This is one of the longest study
18
. 
 
2. Glastin et al the high incidence of hypothyroidism in patients 
treated for malignant lymphomas with significant Pvalue 
(<0.05)
19.
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3. 3.Alterio et al stated that among different types of radiation 
induced thyroid disorders hypothyroidism is the commonest late 
effect with the incidence of 20 to 30%
20
. 
 
In our study we found out 40% incidence of hypothyroidism with one 
year post radiation followup. 
 
INCIDENCE OF HYPOTHYROIDISM COMPARING WITH 
STUDIES 
 incidence  
Einhorn and Wikhokins 7.3 %  
Emami et al 35%  
Alterio et al 20-30%  
Our study 40  %  
Srikantia et al 42%  
 
Table-7 .INCIDENCE OF HYPOTHYROIDISM COMPARING 
WITH STUDIES 
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In our study the followup period was on year post radiation, which 
is lower than other studies.Study conducted by Srikantia et al for the 
period of 9months in 45patient showed  42% had hypothyroidism. 
 
Our study showed comparable  results with the above study. In our 
study 14% developed hypothyroidism at 6months of post RT follow-up 
and 36% had hypothyroidism at 0ne year follow-up of post RT, Among 
them the clinical hypothyroidism is 10% that is 2% in 6months follow-
up and 8% in 1yr follow-up.  
 
In our study more incidence of subclinical  hypothyroidism at one 
year follow-up. Though it is not statically significant detecting 
hypothyroidism at early stage and prevent progression to clinical 
hypothyroidism prevent the complications and further consequences of 
hypothyroidism. The study by Wickams et al showed that patients with 
subclinical hypothyroidism progress to clinical hypothyroidism 38times 
more risk. 
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SEX RATIO AND AGE ANALYSIS. 
 
In our study 10 out of 39 males were found to have  
hypothyroidism , and in females 10 out of 11 were affected. Though the 
smaller sample size, the females are affected more than males. But in our 
control none of the patient had hypothyroidism even though all the 
patients were  females, this is once again proven that the neck irradiation 
is the risk factor. 
 
The study done Weichsel begum RR et al showed the incidence 
of hypothyroidism more in female like general population
21
.In our study 
the age of patient falling between 25 yrs to >66yrs of age. 
 
The mean age of males is 52yrs and the mean age of females were 
59 yrs.6 patients  
 
developed hypothyroidism in patient with <50 yrs of age and 51-
65 yrs 14 patients had Hypothyroidism. this denotes patient with the 
elderly age group affected more compared to younger and older age 
group, this is identical with the study done by Mercado et al
22
. 
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In our study the age and sex was of statically significant with other 
studies.The higher incidence among female patients described by Posner 
et al and Hancock et al with the incidence of hypothyroidism is 20%, the 
relative risk of 1.6:1 in females
21,23
. 
 
The reason for hypothyroidism common in neck irradiated female 
patients: 
1.Autoimmunity:  
 Radiation induced hypothyroidism is a organ specific autoimmune 
disorder, causing epithelial damage as well as necrotizing vacuities and 
thrombosis. Injury to the epithelial tissue leads to release of thyroid 
cellular components that acts as a triggering antigenic stimulus leads to 
production of organ specific Auto antibodies and leads to initiation of 
autoimmune process and thyroid dysfunction.  In autoimmune 
mechanism their must by sustain release of auto antibody following 
antigenic stimuli a genetic susceptibility must be present. 
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 In females it is present in Ir-1 lies within the 
majorhistocompatibility complex. 
 
 In males it is HLA-8 association has been demonstrated for 
autoimmune mechanism.Tamura et al demonstrated raised antibody 
titre following irradiation then they subsequently become hypothyroid. 
 
2.Vascular damage 
Leads to necrotizing vasculitis and thrombosis. 
 
3.Parenchymal damage 
 Leads to thyroid dysfunction by epithelial injury and destruction  
of Parenchyma. 
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COMPARING PRIMARY SITE OF TUMOR WITH STUDIES: 
 In our study the highest percentage of hypothyroidism in 
hypopharyngeal and cancer with the percentage of 24% and another 
study showed highest percentage in laryngeal cancers.The study done by 
Aich et al had the above resulst
24 
In our study 24% 
Aich et al 17% 
 
Table-8.occurence of hypothyroidism with site of primary 
 
 Primary site of tumor was not the tumor not statiscally significant, 
because all the patient had whole neck irradiation received same dose of 
radiation to thyroid gland. 
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CONURRENT CHEMORADIATION VS RADIATION: 
 
Out 50patients studied 35 patients received concurrent chemo 
radiation and 15 received only radiotherapy. Among 35 in concurrent 
CT+RT group 18(36%) had hypothyroidism. 
 
Only RT group 2(4%) out of 15 had hypothyroidism 
 
The use of chemotherapy varies in 
manyinsitutionsforforlocallyadvanced head &neck malignancy , in our 
institute concurrent chemotherapy used in locally advanced head and 
neck cancers to improve the local control and improve the overall 
survival. 
 
In our study 70% of patients receiving concurrent chemo 
radiotherapy were included and 30% of receiving only radiotherapy 
included. 
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Turner et al and Mercado et al showed highest percentage of 
hypothyroidism in concurrent chemo radiotherapy group, which is same 
as our study (2,22 ). 
 
Turner et al showed 77% had hypothyroidism, Mercado et al 
showed 50% had hypothyroidism 
 
Aich et al had 21% incidence of hypothyroidism with concurrent 
radiation and RT received patients only 16%had hypothyroidism (23). 
Occurrence of hypothyroidism with concurrent chemoRT 
Aich et al 21% 
In our study 36% 
Turnr et al 36% 
 
Table-9 . Occurrence of hypothyroidism with concurrent chemoRT 
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RADIATION DOSE COMPARING WITH STUDIES: 
 
 RT DOSE GIVEN MEAN THYROID DOSE 
SRIKANTIA et al >60GY 57GY 
IN OUR STUDY 60-66GY 59GY 
 
Table 10-Radiation dose comparing with studies.: 
 
Srikantia et al they studied 45 patients receiving radiotherapy to 
neck 64.4% received >60gy RT to neck and the mean dose was 60gy,in 
our study among 50 patients 76% received >60gy RT ,the mean dose 
was 59 Gy which is comparable with above study. 
 
 
 
 
 
95 
 
Onset of hypothyroidism 
In our study 6patients developed subclinical hypothyroidism at 
6months,and 1patient developed clinical hypothyroidism at 6months post 
RT. 
 
9 patients developed subclinical hypothyroidism at one year and 
4patients developed clinical at hypothyroidism at one year. These results 
are comparable with other studies. 
 
And also in our study most of patients developed subclinical and clinical 
in one year post RT, compared to 6months following radiation. 
 
Study done by Wichams showed post RT to neck showed patients with 
subclinical hypothyroidism had  38% risk of progression to clinical  
hypothyroidism(24). 
 
Aich et al noticed hypothyroidism at 6weeks post RT, With concurrent 
chemo radiotherapy they had hypothyroidism at 6months post RT. The 
high incidence of hypothyroidism at 2years 20%. 
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All of the studies stated that recognizing subclinical hypothyroidism at a 
early stage and treating the same with thyroxin prevents of clinical 
hypothyroidism, and also preventing cardiac events by reducing lipid 
level, as mentioned by cooper et al(26).  
 
Tell et al study quoted lifelong Thyroid function testing in long 
term survivors of head& neck patient necessary, because the incidence of 
hypothyroidism time and even after long term follow up(27). 
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8. CONCLUSION 
 
Hypothyroidism (clinical or subclinical) is an under rated, 
neglected under-recognized morbidity of external beam radiotherapy to 
neck. In our study included 50 patients with head and neck cancers, 20 
out of 50 had abnormal thyroid values, among which 15out of 50 had 
subclinical hypothyroidism and 5 out of 50 patients had clinical 
hypothyroidism. 
 
The factors associated with the development of hypothyroidism as 
following: 
 
1. Radiation neck  >40 Gy 
2. Female Sex 
3. Post RT duration. 
4. Concurrent chemo radiation. 
 
The radiation to the neck is the only predictive factor which 
strongly associated with development of hypothyroidism. It is proven in 
our study by controls who doesn’t received radiation to neck, not 
developed thyroid dysfunction.  
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Our analysis also found out, female patients progressed to clinical 
hypothyroidism  fast compared to male sex. It is also proven that female 
sex hypothyroidism occurs earlier than males. 
 
 In concurrent chemo radiotherapy group also had higher 
percentage of hypothyroidism. The reason why in the concurrent 
radiotherapy group had hypothyroidism is not known, but may be  
because cisplatin is  a radio sensitizer and it enhances the effect of 
radiation, but it doesn’t cause  thyroid dysfunction per se. Even though it 
is statistically significant, hence because the sample size is small, we 
need a separate study to ascertain this phenomenon, as the sample in our 
study is small. 
 
We also detected the incidence of hypothyroidism increasing 
with time, the progression of subclinical hypothyroidism to clinical 
hypothyroidism occurring with increasing time. So identifying 
subclinical hypothyroidism at an early stage and treating with 
appropriate thyroxin supplementation prevent progression to clinical 
hypothyroidism and its related morbidity.  
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Hereby we strongly recommend, 
 
1. 1.Thyroid function tests should be made routine during follow ups 
from as early as 6weeks and carried out lifelong for long term 
survivors. 
 
2. It is mandatory to keep thyroid function test as a routine for all the 
patients receiving neck irradiation. 
 
3. All patients reviewed by endocrinologist regularly will improve 
the patient quality of life. 
 
4. To create awareness in female patients about the possibility of 
hypothyroidism after radiation 
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IN FUTURE 
 
1. We recommend this study with large sample size and long term 
regular follow up in long-term survivors. 
2. Use of newer technologies like Intensity-Modulated Radiotherapy 
and shielding of thyroid gland can limit dose to thyroid gland, 
which may be tried in future to reduce the occurrence of 
hypothyroidism. 
3. Thyroid gland considered as OAR(organ at risk) and give dose 
constrains to thyroid gland and at the same time dose to target not 
to be compromised. 
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